Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-29T08:23:52.213Z Has data issue: false hasContentIssue false
  • English
  • Français

Stable Colloids of Paclitaxel Nanoparticles Coated with PEGylated Polyelectrolyte Shells

Published online by Cambridge University Press:  07 March 2012

Tatsiana G. Shutava ,
Kirill A. Arapov ,
Pravin P. Pattekari ,
Yuri M. Lvov ,
Tatyana S. Levchenko ,
Rupa R. Sawant  and
Vladimir P. Torchilin
Tatsiana G. Shutava
Affiliation:
Institute for Micromanufacturing, Louisiana Tech University, 911 Hergot Ave., Ruston, LA 71272, U.S.A.
Kirill A. Arapov
Affiliation:
Institute for Micromanufacturing, Louisiana Tech University, 911 Hergot Ave., Ruston, LA 71272, U.S.A.
Pravin P. Pattekari
Affiliation:
Institute for Micromanufacturing, Louisiana Tech University, 911 Hergot Ave., Ruston, LA 71272, U.S.A.
Yuri M. Lvov
Affiliation:
Institute for Micromanufacturing, Louisiana Tech University, 911 Hergot Ave., Ruston, LA 71272, U.S.A.
Tatyana S. Levchenko
Affiliation:
Department of Pharmaceutical Sciences, Northeastern University, 360 Huntington Ave., Boston, MA 02115, U.S.A.
Rupa R. Sawant
Affiliation:
Department of Pharmaceutical Sciences, Northeastern University, 360 Huntington Ave., Boston, MA 02115, U.S.A.
Vladimir P. Torchilin
Affiliation:
Department of Pharmaceutical Sciences, Northeastern University, 360 Huntington Ave., Boston, MA 02115, U.S.A.
Get access

Abstract

A novel nanoparticulated form of the poorly water-soluble anticancer drug paclitaxel (PTX) suitable for intravenous administration has been developed using sonication-assisted layer-by-layer (LbL) assembly. The nanoparticles contain up to 70 wt.% of the drug and consist of 150-180 nm solid crystal paclitaxel cores coated with 20-30 nm thick shells of alternative layers of PEGylated poly-L-lysine and heparin. Dispersions of PTX nanoparticles are stable in different biological solvents at concentrations up to 5 mg/ml. Intravenous administration of the LbL-coated nano-crystalline PTX to mice via tail injection provided the preliminary confirmation of their safety and tolerability.

Keywords

colloidlayeredcoating
Type
Research Article
Information
MRS Online Proceedings Library (OPL) , Volume 1416: Symposium JJ – Nanofunctional Materials, Nanostructures and Nanodevices for Cancer Applications , 2012 , mrsf11-1416-jj05-32
Copyright
Copyright © Materials Research Society 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Ferrente, K., Winograd, B. and Canetta, R., Cancer Chemother. Pharmacol. 43, S61 (1999).Google Scholar
2. Feng, S. and Huang, G., J. Control. Release 71, 53 (2001); F. Li, J. Li, X. Wen, S. Zhou, X. Tong, P. Su, H. Li and D. Shi; Material Science and Engineering C 29, 2392(2009).Google Scholar
3. Kim, S., Kim, J. Y., Huh, K.M., Acharya, G. and Park, K., J. Control. Release 132, 222 (2008); Y.W. Cho, J. Lee, S.C. Lee, K.M. Huh and K. Park, J. Control. Release 97, 249(2004).Google Scholar
4. Wei, X. H., Nui, Y. P., Xu, Y. Y., Du, Y. Z., Hu, F.Q. and Yuan, H., Journal of Bioactive and Compatible Polymers 25, 319 (2010).Google Scholar
5. Zahr, A.S. and Pishko, M.V., Biomacromolecules 8(6), 2004 (2007); X. Yu and M.V. Pishko, Biomacromolecules 2(9), 3205(2011).Google Scholar
6. Luxenhofer, R., Schulz, A., Roques, C., Li, S., Bronich, T., Batrakova, E., Jordan, R. and Kabanov, A., Biomaterials 31, 4972 (2010).Google Scholar
7. Lvov, Y. in Protein Architecture: Interfacial Molecular Assembly and Immobilization Biotechnology, ed. Lvov, Y. and Möhwald, H. (Marcel Dekker Publ., NY, 2000) pp. 1–394;Google Scholar
8. Lvov, Y., Pattekari, P., Zhang, X., Torchilin, V., Langmuir 27, 1212 (2011).Google Scholar
9. Ishihara, T., Maeda, T., Sakamoto, H., Takasaki, N., Shigyo, M., Ishida, T., Kiwada, H., , Y.; Mizushima, and Mizushima, T., Biomacromolecules 11, 2700 (2010).Google Scholar
10. Guo, Y., Sun, Y., Gu, J. and Xu, Y., Analytical Biochemistry 363, 204 (2007).Google Scholar
11. Banchev, G., Lu, Z. and Lvov, Y., J. Nanosci. Nanotech. 9, 396 (2009).Google Scholar
12. Boudou, T., Kharkar, P., Jing, J., Guillot, R., Pignot-Paintrand, I., Auzely-Velty, R. and Picart, C., J. Control. Release DOI: 10.1016/j.jconrel.2012.01.022 (2012).Google Scholar
13. You, J., Hu, F.-Q., Du, Y., Yuan, H. and Ye, B., Nanotechnology 18, 495101 (2007).Google Scholar
14. De Geest, B., Sukhorukov, G., Möhwald, H., Expert Opinions Drug Deliv. 6, 613 (2009), and M. Bédard, B. De Geest, A. Skirtach, H. Möhwald, G. Sukhorukov, Adv. Colloid Interface Sci. 158, 2(2010).Google Scholar
15. Shutava, T., Balkundi, S., Vangala, P., O’Neal, P., Steffan, J., Bigelow, R., Cardelli, J., Lvov, Y., ACS Nano, 3, 1877 (2009).Google Scholar